# A Study of LY2216684 and Theophylline in Healthy Subjects

> **NCT01263106** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 21 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** LY2216684
- **DRUG:** Theophylline

## Key facts

- **NCT ID:** NCT01263106
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01263106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01263106, "A Study of LY2216684 and Theophylline in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01263106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*